Sustained attention in school-age children with congenital hypothyroidism: Influence of episodes of overtreatment in the first three years of life

Neurologia (Engl Ed). 2020 May;35(4):226-232. doi: 10.1016/j.nrl.2017.08.003. Epub 2017 Nov 20.
[Article in English, Spanish]

Abstract

Introduction: Children with congenital hypothyroidism (CH) are at risk of developing mild cognitive impairment despite normal overall intellectual performance. These deficits may be caused by disease-related and treatment-related factors. This study explores the impact of abnormal thyroid function during the first 3 years of life on attention performance at school age.

Methods: We included 49 children diagnosed with CH and receiving treatment for the condition: 14 boys (mean age 9.5±2.8 years) and 35 girls (9.6±2.6 years). The number of episodes of normal, under-, and overtreatment were estimated based on TSH levels during their first 3 years of life (at 12, 18, 24, 30, and 36 months). Children were assessed using a computerised version of a Sustained attention test. General linear models were calculated with the attention index as the dependent variable and sex, aetiology, and number of episodes of normal, under-, and overtreatment as independent variables.

Results: Higher numbers of episodes of overtreatment (low TSH level) were associated with poorer attention performance at school age (P=.005, r=-0.45).

Conclusions: Children with CH should be monitored closely during the first 3 years of life in order to prevent not only hypothyroidism but also any adverse effects of overtreatment that may affect attentional function at school age.

Keywords: Atención sostenida; Cognición; Cognition; Congenital hypothyroidism; Control endocrino; Endocrine control; Hipotiroidismo congénito; Sustained attention.

MeSH terms

  • Attention / physiology*
  • Child
  • Child, Preschool
  • Congenital Hypothyroidism / drug therapy*
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Medical Overuse*
  • Schools
  • Spain
  • Thyrotropin / analysis*
  • Thyroxine / therapeutic use*

Substances

  • Thyrotropin
  • Thyroxine